A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration
Clinical trial NCT07718165 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07718165
- Sponsor
- Abbisko Therapeutics Co, Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-12-30
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.